Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 37 páginas
Examen

APEA WOMEN’S HEALTH FINAL EXAM PRACTICE QUESTIONS/APEA WOMEN’S HEALTH FINAL EXAM QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES LATEST 2026 (100% VERIFIED ANSWERS) ALREADY GRADED A+

Document preview thumbnail
Vista previa 4 fuera de 37 páginas

APEA WOMEN’S HEALTH FINAL EXAM PRACTICE QUESTIONS/APEA WOMEN’S HEALTH FINAL EXAM QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES LATEST 2026 (100% VERIFIED ANSWERS) ALREADY GRADED A+

Vista previa del contenido

APEA WOMEN’S HEALTH FINAL EXAM PRACTICE
QUESTIONS/APEA WOMEN’S HEALTH FINAL EXAM
QUESTIONS AND CORRECT DETAILED ANSWERS WITH
RATIONALES LATEST 2026 (100% VERIFIED ANSWERS)
ALREADY GRADED A+




1. A 24-year-old woman presents for her annual well-woman examination. She is sexually
active with one partner and has no history of cervical dysplasia. According to current cervical
cancer screening recommendations, which screening should be performed?

A. Pap smear annually

B. Pap smear every 3 years

C. HPV testing annually

D. Pap smear and HPV co-testing every year

Answer: B

Rationale: Women aged 21–29 years who are at average risk should undergo cervical cytology
(Pap smear) every 3 years. Routine HPV testing is not recommended in this age group because
transient HPV infections are common and usually resolve spontaneously. Annual Pap smears
are no longer recommended because they increase unnecessary follow-up procedures
without improving patient outcomes.

2. A 33-year-old woman presents for a preventive health visit. She has had consistently
normal cervical cancer screening results. Which screening strategy is most appropriate?

A. Pap smear every year

B. Pap smear every 2 years

C. Primary HPV testing every 5 years

D. HPV testing every year

,Answer: C

Rationale: Women aged 30–65 years at average risk may undergo primary HPV testing every 5
years, HPV/Pap co-testing every 5 years, or cytology alone every 3 years. Primary HPV testing
every 5 years is one of the preferred screening options.

3. A 22-year-old woman requests contraception. She has a history of migraine with aura.
Which contraceptive method is contraindicated?

A. Copper IUD

B. Levonorgestrel-releasing IUD

C. Etonogestrel implant

D. Combined oral contraceptive pill

Answer: D

Rationale: Estrogen-containing contraceptives increase the risk of ischemic stroke in women
with migraine with aura and are contraindicated. Progestin-only methods and intrauterine
devices are safe alternatives.

4. A woman taking combined oral contraceptives forgot one active pill yesterday. What is the
most appropriate recommendation?

A. Stop the current pack and restart next month.

B. Begin emergency contraception immediately.

C. Take the missed pill as soon as remembered and continue the remaining pills as scheduled.

D. Skip the missed pill and continue with the next scheduled pill.

Answer: C

Rationale: If one active pill is missed, it should be taken as soon as remembered, even if two
pills are taken in one day. The remaining pills should then be continued as scheduled.
Emergency contraception is generally not required after missing only one pill.

5. Which patient is the best candidate for a copper intrauterine device (IUD)?

A. A woman with active pelvic inflammatory disease

B. A woman with unexplained vaginal bleeding

C. A woman desiring highly effective long-term hormone-free contraception

,D. A woman who is currently pregnant

Answer: C

Rationale: The copper IUD is a highly effective, long-acting, hormone-free contraceptive that
provides protection for up to 10 years. It is contraindicated in pregnancy, active pelvic
infection, or unexplained abnormal uterine bleeding until evaluation is completed.



6. Which organism is most commonly associated with bacterial vaginosis?

A. Candida albicans

B. Trichomonas vaginalis

C. Neisseria gonorrhoeae

D. Gardnerella vaginalis

Answer: D

Rationale: Bacterial vaginosis results from disruption of the normal vaginal flora with
overgrowth of anaerobic organisms, particularly Gardnerella vaginalis. Clinical findings
include thin gray-white discharge, a fishy odor, vaginal pH greater than 4.5, and clue cells on
wet mount. Metronidazole or clindamycin is the recommended treatment.

7. A 26-year-old woman reports intense vulvar itching and thick white vaginal discharge. Her
vaginal pH is 4.2. Which diagnosis is most likely?

A. Bacterial vaginosis

B. Trichomoniasis

C. Gonorrhea

D. Vulvovaginal candidiasis

Answer: D

Rationale: Vulvovaginal candidiasis is characterized by intense pruritus, vulvar erythema,
dysuria, dyspareunia, and thick white "cottage cheese" discharge. Vaginal pH typically
remains normal (less than 4.5). Fluconazole or topical azole therapy is the standard treatment



8. A patient presents with frothy yellow-green vaginal discharge, vulvar irritation, and a
strawberry cervix on pelvic examination. Which medication is first-line therapy?

, A. Fluconazole

B. Clindamycin cream

C. Azithromycin

D. Metronidazole

Answer: D

Rationale: The patient's symptoms are classic for Trichomonas vaginalis infection. The CDC
recommends oral metronidazole as the first-line treatment because it effectively eradicates
the parasite. Intravaginal metronidazole is not effective for trichomoniasis. Sexual partners
should also be treated simultaneously, and the patient should abstain from sexual activity
until both partners have completed treatment and symptoms have resolved.

9. Which vaginal infection typically produces a vaginal pH greater than 4.5?

A. Vulvovaginal candidiasis

B. Bacterial vaginosis

C. Physiologic leukorrhea

D. Atrophic vaginitis in reproductive-aged women

Answer: B

Rationale: Bacterial vaginosis is characterized by a vaginal pH greater than 4.5 due to the loss
of Lactobacillus species and overgrowth of anaerobic bacteria. Vulvovaginal candidiasis
generally has a normal vaginal pH (4.0–4.5). Although trichomoniasis also raises vaginal pH, it
is not listed as an option.

10. Which finding is most characteristic of pelvic inflammatory disease (PID)?

A. Painless vaginal bleeding

B. Thick white vaginal discharge

C. Cervical motion tenderness

D. Vulvar ulcerations

Answer: C

Rationale: Cervical motion tenderness is one of the hallmark physical examination findings of
PID. Patients often also have uterine tenderness, adnexal tenderness, fever, abnormal vaginal

Información del documento

Subido en
19 de julio de 2026
Número de páginas
37
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$21.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Vendido
1
Seguidores
0
Artículos
235
Última venta
3 meses hace


Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes